Dimensional Fund Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-371,752
| Closed | -$357K | – | 3544 |
|
|
2023
Q2 | $357K | Sell |
371,752
-40
| -0% | -$40 | ﹤0.01% | 3131 |
|
|
2023
Q1 | $279K | Sell |
371,792
-67,931
| -15% | -$49.6K | ﹤0.01% | 3139 |
|
|
2022
Q4 | $162 | Hold |
439,723
| – | – | ﹤0.01% | 3262 |
|
|
2022
Q3 | $189K | Sell |
439,723
-20,162
| -4% | -$19.8K | ﹤0.01% | 3250 |
|
|
2022
Q2 | $358K | Sell |
459,885
-70,060
| -13% | -$61.7K | ﹤0.01% | 3141 |
|
|
2022
Q1 | $683K | Sell |
529,945
-390,778
| -42% | -$360K | ﹤0.01% | 3078 |
|
|
2021
Q4 | $1.17M | Sell |
920,723
-483,203
| -34% | -$864K | ﹤0.01% | 2994 |
|
|
2021
Q3 | $3.06M | Sell |
1,403,926
-433,727
| -24% | -$1.19M | ﹤0.01% | 2725 |
|
|
2021
Q2 | $6.89M | Sell |
1,837,653
-158,149
| -8% | -$550K | ﹤0.01% | 2504 |
|
|
2021
Q1 | $6.53M | Buy |
1,995,802
+361,571
| +22% | +$1.3M | ﹤0.01% | 2482 |
|
|
2020
Q4 | $5.58M | Sell |
1,634,231
-278,410
| -15% | -$1.15M | ﹤0.01% | 2493 |
|
|
2020
Q3 | $7.8M | Buy |
1,912,641
+122,287
| +7% | +$465K | ﹤0.01% | 2307 |
|
|
2020
Q2 | $6.05M | Sell |
1,790,354
-39,223
| -2% | -$114K | ﹤0.01% | 2410 |
|
|
2020
Q1 | $4.26M | Buy |
1,829,577
+300,380
| +20% | +$822K | ﹤0.01% | 2475 |
|
|
2019
Q4 | $5.57M | Buy |
1,529,197
+216,213
| +16% | +$1.75M | ﹤0.01% | 2574 |
|
|
2019
Q3 | $10.9M | Buy |
1,312,984
+85,345
| +7% | +$690K | ﹤0.01% | 2310 |
|
|
2019
Q2 | $10.6M | Buy |
1,227,639
+215,734
| +21% | +$1.93M | ﹤0.01% | 2377 |
|
|
2019
Q1 | $10.8M | Buy |
1,011,905
+11,660
| +1% | +$125K | ﹤0.01% | 2372 |
|
|
2018
Q4 | $8.75M | Buy |
1,000,245
+263,961
| +36% | +$3.36M | ﹤0.01% | 2404 |
|
|
2018
Q3 | $12.4M | Sell |
736,284
-382,753
| -34% | -$8.28M | ﹤0.01% | 2341 |
|
|
2018
Q2 | $23.5M | Sell |
1,119,037
-1,298,911
| -54% | -$24.1M | 0.01% | 2023 |
|
|
2018
Q1 | $38.9M | Sell |
2,417,948
-44,959
| -2% | -$891K | 0.02% | 1595 |
|
|
2017
Q4 | $46.7M | Sell |
2,462,907
-81,994
| -3% | -$1.49M | 0.02% | 1427 |
|
|
2017
Q3 | $35.8M | Sell |
2,544,901
-129,778
| -5% | -$1.17M | 0.02% | 1631 |
|
|
2017
Q2 | $19.9M | Buy |
2,674,679
+463,434
| +21% | +$3.03M | 0.01% | 2030 |
|
|
2017
Q1 | $14.4M | Buy |
2,211,245
+240,614
| +12% | +$1.35M | 0.01% | 2161 |
|
|
2016
Q4 | $8.73M | Buy |
1,970,631
+181,018
| +10% | +$759K | ﹤0.01% | 2356 |
|
|
2016
Q3 | $8.36M | Buy |
1,789,613
+402,850
| +29% | +$2.39M | ﹤0.01% | 2323 |
|
|
2016
Q2 | $9.11M | Buy |
1,386,763
+162,704
| +13% | +$1.15M | 0.01% | 2267 |
|
|
2016
Q1 | $7.79M | Buy |
1,224,059
+20,932
| +2% | +$107K | ﹤0.01% | 2311 |
|
|
2015
Q4 | $7.25M | Sell |
1,203,127
-32,031
| -3% | -$183K | ﹤0.01% | 2361 |
|
|
2015
Q3 | $7.39M | Sell |
1,235,158
-2,844
| -0.2% | -$19.7K | ﹤0.01% | 2355 |
|
|
2015
Q2 | $8.47M | Sell |
1,238,002
-13,648
| -1% | -$86.7K | 0.01% | 2355 |
|
|
2015
Q1 | $7.6M | Sell |
1,251,650
-1,817
| -0.1% | -$12.1K | ﹤0.01% | 2372 |
|
|
2014
Q4 | $8.69M | Buy |
1,253,467
+8,900
| +0.7% | +$65.4K | 0.01% | 2332 |
|
|
2014
Q3 | $10.1M | Sell |
1,244,567
-3,673
| -0.3% | -$28.7K | 0.01% | 2196 |
|
|
2014
Q2 | $10.1M | Sell |
1,248,240
-6,075
| -0.5% | -$46.1K | 0.01% | 2214 |
|
|
2014
Q1 | $9.83M | Sell |
1,254,315
-4,600
| -0.4% | -$38.9K | 0.01% | 2202 |
|
|
2013
Q4 | $11.1M | Sell |
1,258,915
-15,330
| -1% | -$137K | 0.01% | 2073 |
|
|
2013
Q3 | $10.7M | Sell |
1,274,245
-18,746
| -1% | -$152K | 0.01% | 2061 |
|
|
2013
Q2 | $9.65M | Buy |
+1,292,991
| New | +$9.92M | 0.01% | 2033 |
|
Dimensional Fund Advisors's SPPI Position: Q3 2023 in Review
Dimensional Fund Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 371,752 shares — an estimated $357K sold.
Dimensional Fund Advisors first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $46.7M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Dimensional Fund Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Dimensional Fund Advisors sold 371,752 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $357K.
- Dimensional Fund Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- Dimensional Fund Advisors's Spectrum Pharmaceuticals Inc position peaked at $46.7M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.